DiCE Molecules
Craig Skinner is a scientist at DiCE Molecules since April 2016, specializing in biochemistry and molecular biology. Prior experience includes serving as a Research Molecular Biologist at USDA-WRRC, where purification protocols for Shiga-like toxins were developed and properties of purified toxins were examined. Craig completed a doctorate at the University of California, Berkeley, focusing on yeast life span and calorie restriction, following a Bachelor's degree in Biochemistry/Cell Biology from the same institution. Early career contributions include research roles at Maxygen, Inc. and UCSF, where work focused on vaccine development and mouse genetic studies, respectively.
This person is not in any offices
DiCE Molecules
DiCE Molecules designs and develops innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, they are developing oral alternatives to medicines currently limited to injectable forms.